Lanoxin PG 50 micrograms/ml Elixir
- Name:
Lanoxin PG 50 micrograms/ml Elixir
- Company:
Aspen
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 22/01/19
(Click to Download)XPIL
PACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER
1. What Lanoxin PG Elixir is and what it is used for
1. What Lanoxin PG Elixir is and what it is used for
2. What you need to know before you use Lanoxin PG Elixir
2. What you need to know before you use Lanoxin PG Elixir
3. How to take Lanoxin PG Elixir
3. How to take Lanoxin PG Elixir
4. Possible side effects
4. Possible side effects
5. How to store Lanoxin PG Elixir
5. How to store Lanoxin PG Elixir
6. Contents of the pack and other information
6. Contents of the pack and other information
Click on this link to Download PDF directly
Aspen
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 30 April 2019 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 22 January 2019 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - excipient warnings
- Change to section 3 - dose and frequency
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 5 February 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 5 February 2018 PIL
Reasons for updating
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
Updated on 18 April 2017 PIL
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children and adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 2 - driving and using machines
- Change to section 3 - dose and frequency
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 8 April 2014 PIL
Reasons for updating
- Change to date of revision
- Change to MA holder contact details
Updated on 19 November 2013 PIL
Reasons for updating
- Change of active ingredient
- Change to, or new use for medicine
- Change to warnings or special precautions for use
- Change to storage instructions
- Change to side-effects
- Change to information about pregnancy or lactation
- Change to information about driving or using machinery
- Change to date of revision
- Change to dosage and administration
- Addition of information on alternative format leaflets
Updated on 30 January 2013 PIL
Reasons for updating
- Improved electronic presentation
Updated on 27 May 2011 PIL
Reasons for updating
- Change to marketing authorisation holder
Updated on 12 March 2010 PIL
Reasons for updating
- Change to marketing authorisation holder
Updated on 31 January 2006 PIL
Reasons for updating
- Improved electronic presentation
Updated on 26 May 2005 PIL
Reasons for updating
- New PIL for medicines.ie